Compounds > 2,3-dinor-thromboxane b2

2,3-dinor-thromboxane b2 and Pulmonary Hypertension

2,3-dinor-thromboxane b2 has been researched along with Pulmonary Hypertension in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adatia, I; Barrow, SE; Haworth, SG; Miall-Allen, VM; Ritter, JM; Stratton, PD1
Bernard, GR; Christman, BW; Groves, BM; King, GA; Loyd, JE; McPherson, CD; Newman, JH1
Cotton, RB; Kühl, PG; Schweer, H; Seyberth, HW1

Other Studies

3 other study(ies) available for 2,3-dinor-thromboxane b2 and Pulmonary Hypertension

ArticleYear
Thromboxane A2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease.
    Circulation, 1993, Volume: 88, Issue:5 Pt 1

    Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Aging; Cardiac Surgical Procedures; Child; Child, Preschool; Epoprostenol; Female; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Infant; Male; Postoperative Period; Pulmonary Heart Disease; Reference Values; Thromboxane A2; Thromboxane B2

1993
An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension.
    The New England journal of medicine, 1992, Jul-09, Volume: 327, Issue:2

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Epoprostenol; Female; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive; Male; Radioimmunoassay; Thromboxane A2; Thromboxane B2

1992
Endogenous formation of prostanoids in neonates with persistent pulmonary hypertension.
    Archives of disease in childhood, 1989, Volume: 64, Issue:7 Spec No

    Topics: 6-Ketoprostaglandin F1 alpha; Bacterial Infections; Epoprostenol; Female; Humans; Hypertension, Pulmonary; Infant, Newborn; Male; Thromboxane A2; Thromboxane B2

1989